Skip to main content

Table 1 Characteristics of individual studies included in the meta-analysis

From: Prognostic significance of Epstein-Barr virus infection in gastric cancer: a meta-analysis

Study

Region

Year

EBV-positive/EBV-negative

Statistical methodology

HR estimation

Study quality score

Gonzalez CA

Europe

2003

4/83

UA

HR + 95 % CI

6/9

Chow WH

Europe

1999

11/76

UA

HR + 95 % CI

5/9

Kim RH

Asia

2010

18/229

UA

HR + 95 % CI

9/9

Gulley ML

Americas

1996

11/84

UA

HR + 95 % CI

8/9

Corvalán A

Americas

2005

22/71

UA

HR + 95 % CI

9/9

van Beek J

Europe

2004

41/525

UA

survival curves

8/9

He Y

Asia

2012

21/97

UA

HR + 95 % CI

7/9

Herrera-Goepfert R

Americas

2005

8/127

UA

HR + 95 % CI

5/9

Corvalan A

Americas

2001

27/118

UA

HR + 95 % CI

6/9

Koriyama C

Asia

2007

49/100

UA

HR + 95 % CI

8/9

Boysen T

Europe

2011

18/168

UA

HR + 95 % CI

7/9

Nakao M

Asia

2011

20/351

UA

HR + 95 % CI

5/9

Sukawa Y

Asia

2012

18/204

UA

HR + 95 % CI

7/9

Chiaravalli AM

Europe

2006

18/78

UA

RR + 95 % CI

7/9

Gao Y

Asia

2009

21/1018

UA

HR + 95 % CI

7/9

Kijima Y

Asia

2003

25/334

UA

HR + 95 % CI

9/9

Koriyama C

Asia

2002

64/128

MA

HR + 95 % CI

6/9

Park ES

Asia

2009

50/407

MA

HR + 95 % CI

7/9

Song HJ

Asia

2010

123/405

UA

HR + 95 % CI

8/9

Grogg KL

Americas

2003

7/103

UA

RR + 95 % CI

9/9

Zhao J

Asia

2012

80/631

UA

survival curves

7/9

Huang SC

Asia

2014

51/943

UA

HR + 95 % CI

8/9

Lee HS

Asia

2004

63/1051

UA

HR + 95 % CI

7/9

Truong CD

Americas

2009

12/223

MA

RR + 95 % CI

8/9

  1. Abbreviations: EBV Epstein-Barr Virus, HR hazard ratio, CI confidence interval, UA univariate analysis, MA multivariate analysis